Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 20 peer-reviewed journal articles Updated
Hematology

Understanding Your Diagnosis: Idiopathic HES

At a Glance

Idiopathic hypereosinophilic syndrome means eosinophils are persistently high and are affecting one or more organs, but testing has not found a specific cause. Diagnosis involves ruling out other conditions and monitoring organ health, especially the heart.

Receiving a diagnosis of Idiopathic Hypereosinophilic Syndrome (iHES) can feel like entering a new and unfamiliar world. You may have spent months or even years visiting different doctors to find an answer for your symptoms—a process often called the “diagnostic odyssey” [1]. Understanding what this diagnosis means, why it is called “idiopathic,” and how your body’s own immune cells are behaving is the first step in managing your health.

Defining Your Diagnosis

Hypereosinophilic Syndrome (HES) is a rare condition defined by two main factors:

  1. High Eosinophil Levels: Your Absolute Eosinophil Count (AEC) is higher than 1,500 cells per microliter (µL) of blood (or 1.5 × 10^9/L) [2]. Current guidelines emphasize persistent hypereosinophilia rather than a strict time interval, meaning your doctors will look for sustained high levels [3].
  2. Organ Involvement: The high level of eosinophils is not just a laboratory finding; it is actively causing damage or inflammation in your organs, such as your skin, heart, lungs, or digestive system [4][3].

The word idiopathic means that after extensive testing, your doctors cannot find a specific “trigger” or underlying cause for the high eosinophil count [5]. It is considered a diagnosis of exclusion, meaning it is only given after your care team has evaluated and ruled out other possibilities, such as parasitic infections, drug reactions, or specific genetic mutations in the blood cells [6][7].

The Rarity of HES

HES is an ultra-rare condition. Data from the UK suggests that the number of new cases diagnosed each year (incidence) is between 0.04 and 0.17 per 100,000 person-years [8]. At any given time, only about 1 in 112,000 to 1 in 660,000 people in the general population are living with a recorded diagnosis of HES [8]. Because it is so rare, many people find that they must become their own best advocates, often educating those around them about the condition. It’s important to remember that these numbers are broad population statistics, not individual predictions for your life.

The Role of Eosinophils

To understand HES, it helps to know what eosinophils (a type of white blood cell) normally do. In a healthy body, they are helpful “soldiers” of the immune system that:

  • Fight Infections: They are particularly good at defending you against parasites and certain viruses [9].
  • Maintain Balance: They help regulate inflammation and keep your tissues healthy and stable [10].

In HES, however, the body produces too many of these cells, and they become overactive. When too many eosinophils gather in one place, they can release toxic proteins and chemicals that were meant to kill parasites, but instead damage your own healthy tissues [11][12]. This process can lead to:

  • Inflammation: Swelling and redness in various parts of the body [13].
  • Fibrosis: The formation of “scar tissue” that can make organs stiff and less functional [14].
  • Thrombosis: An increased risk of blood clots [15].

The heart is one of the most important organs to monitor in HES. Eosinophils can cause the heart muscle to become inflamed (myocarditis) or scarred, which can eventually affect how well the heart pumps blood [14][16]. Interestingly, the level of eosinophils in your blood does not always match the amount of damage happening in your tissues, which is why your doctor will focus on how your organs are functioning, not just your blood test numbers [17].

Navigating the Emotional Impact

Finding out you have a rare, “idiopathic” disease is often an emotional burden. It is common to feel a mix of:

  • Uncertainty: The label “idiopathic” can feel unsatisfying because it doesn’t explain why this happened to you [18].
  • Isolation: Because few people have heard of HES, you may feel like others don’t truly understand your experience [19].
  • Relief: After a long search for answers, finally having a name for your symptoms can be a source of validation [1].

These feelings are a normal part of the rare-disease journey. While the diagnosis provides a solid working framework, it is the beginning of an ongoing partnership with your medical team to protect your health and manage your symptoms [19][20].

Common questions in this guide

What does an idiopathic HES diagnosis mean?
Hypereosinophilic syndrome means that eosinophils, a type of white blood cell, are abnormally high and are causing inflammation or damage in the body. Idiopathic means that testing did not find a specific underlying cause, such as an infection, medication reaction, or certain blood-cell changes.
How is idiopathic hypereosinophilic syndrome diagnosed?
Doctors look for a persistently high absolute eosinophil count, generally above 1,500 cells per microliter of blood, along with organ inflammation or damage. They also evaluate and rule out other causes, including parasitic infections, drug reactions, and specific genetic or blood disorders.
Can my eosinophil blood count show how much organ damage I have?
Not always. The eosinophil level in blood may not match the amount of damage in tissues, so doctors also consider symptoms, organ-function tests, and other markers when monitoring HES.
Why is heart monitoring important with idiopathic HES?
Eosinophils can cause inflammation or scarring in the heart, which may affect how well it pumps blood. Your care team may use tests such as an echocardiogram or cardiac MRI to evaluate heart health and decide how often monitoring is needed.
Should I see a specialist who has experience with HES?
HES is rare, so it can be helpful to ask whether your care team regularly manages the condition. Your doctors may recommend consultation with a specialist or center experienced in HES, especially when diagnosis or organ monitoring is complex.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What specific tests were used to rule out secondary causes, such as infections or other blood disorders, before giving me this 'idiopathic' diagnosis?
  2. 2.Has my heart been fully evaluated with an echocardiogram or cardiac MRI, and how often will you monitor my heart health going forward?
  3. 3.Since my blood count might not always reflect the amount of tissue damage, what other markers or symptoms will we use to track my progress?
  4. 4.Given the rarity of HES, does our care team have experience managing this specific condition, or should we consult with a specialist center?
  5. 5.How many times was my absolute eosinophil count (AEC) measured to confirm the diagnosis, and what was the highest level recorded?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (20)
  1. 1

    Evidence of inequities experienced by the rare disease community with respect to receipt of a diagnosis and access to services: a scoping review of UK and international evidence.

    Briscoe S, Martin Pintado C, Sutcliffe K, et al.

    Orphanet journal of rare diseases 2025; (20(1)):303 doi:10.1186/s13023-025-03818-w.

    PMID: 40506782
  2. 2

    [Eosinophilia: hypereosinophilic syndrome vs. eosinophilic granulomatosis with polyangiitis].

    Holle JU, Moosig F

    Zeitschrift fur Rheumatologie 2023; (82(4)):307-320 doi:10.1007/s00393-023-01345-2.

    PMID: 37099180
  3. 3

    Cardiac Abnormalities in Hypereosinophilic Syndromes.

    Hotta VT, Nastari RR, Oishi GDSL, et al.

    Arquivos brasileiros de cardiologia 2024; (121(10)):e20240190 doi:10.36660/abc.20240190.

    PMID: 39607243
  4. 4

    Beyond eosinophil counts: organ involvement patterns across hypereosinophilic syndrome subtypes in a single-center cohort.

    Nicola S, Negrini S, Lo Sardo L, et al.

    Frontiers in immunology 2026; (17()):1933052 doi:10.3389/fimmu.2026.1933052.

    PMID: 42688361
  5. 5

    Severe Persistent Hypereosinophilia of Undetermined Significance: Diagnostic Challenges in Clinical Practice and Two-Year Follow-Up.

    Leru PM, Anton VF, Georgescu DG

    Romanian journal of internal medicine = Revue roumaine de medecine interne 2026; doi:10.2478/rjim-2026-0014.

    PMID: 42335361
  6. 6

    Eosinophilic Myocarditis.

    Cheung CC, Constantine M, Ahmadi A, et al.

    The American journal of the medical sciences 2017; (354(5)):486-492 doi:10.1016/j.amjms.2017.04.002.

    PMID: 29173361
  7. 7

    World Health Organization-defined eosinophilic disorders: 2017 update on diagnosis, risk stratification, and management.

    Gotlib J

    American journal of hematology 2017; (92(11)):1243-1259 doi:10.1002/ajh.24880.

    PMID: 29044676
  8. 8

    The increasing incidence and prevalence of hypereosinophilic syndrome in the United Kingdom.

    Requena G, Logie J, Gibbons DC, et al.

    Immunity, inflammation and disease 2021; (9(4)):1447-1451 doi:10.1002/iid3.495.

    PMID: 34293251
  9. 9

    Multiple Biological Aspects of Eosinophils in Host Defense, Eosinophil-Associated Diseases, Immunoregulation, and Homeostasis: Is Their Role Beneficial, Detrimental, Regulator, or Bystander?

    Kanda A, Yasutaka Y, Van Bui D, et al.

    Biological & pharmaceutical bulletin 2020; (43(1)):20-30 doi:10.1248/bpb.b19-00892.

    PMID: 31902927
  10. 10

    The multiple functions and subpopulations of eosinophils in tissues under steady-state and pathological conditions.

    Kanda A, Yun Y, Bui DV, et al.

    Allergology international : official journal of the Japanese Society of Allergology 2021; (70(1)):9-18 doi:10.1016/j.alit.2020.11.001.

    PMID: 33243693
  11. 11

    Pro-inflammatory and counter-regulatory modulators of interleukin-5-driven eosinophil programs: a framework for precision medicine in eosinophilic diseases.

    Sasaki H, Miyata J, Fukunaga K

    Frontiers in immunology 2026; (17()):1836661 doi:10.3389/fimmu.2026.1836661.

    PMID: 42058205
  12. 12

    Adhesion-induced eosinophil cytolysis requires the receptor-interacting protein kinase 3 (RIPK3)-mixed lineage kinase-like (MLKL) signaling pathway, which is counterregulated by autophagy.

    Radonjic-Hoesli S, Wang X, de Graauw E, et al.

    The Journal of allergy and clinical immunology 2017; (140(6)):1632-1642 doi:10.1016/j.jaci.2017.01.044.

    PMID: 28412393
  13. 13

    Eosinophil-derived IL-4 drives progression of myocarditis to inflammatory dilated cardiomyopathy.

    Diny NL, Baldeviano GC, Talor MV, et al.

    The Journal of experimental medicine 2017; (214(4)):943-957 doi:10.1084/jem.20161702.

    PMID: 28302646
  14. 14

    The three stages of eosinophilic cardiac damage: A series of case reports.

    Ferreira J, Gonçalves S, Duarte T, et al.

    Journal of cardiology cases 2024; (30(1)):5-8 doi:10.1016/j.jccase.2024.02.013.

    PMID: 39007045
  15. 15

    Multiple Cerebral Infarcts and Encephalopathy as the First Clinical Manifestations of Hypereosinophilic Syndrome: A Case Report and Narrative Review.

    Romano S, Avola G, Angeli MC, et al.

    Pulse (Basel, Switzerland) 2024; (12(1)):106-112 doi:10.1159/000539379.

    PMID: 39473614
  16. 16

    Hypereosinophilia causes progressive cardiac pathologies in mice.

    Diny NL, Wood MK, Won T, et al.

    iScience 2023; (26(10)):107990 doi:10.1016/j.isci.2023.107990.

    PMID: 37829205
  17. 17

    Paraneoplastic Hypereosinophilia With Multisystem Involvement as an Atypical Presentation of Lung Adenocarcinoma.

    Bravo S, Machado A, Medeiros P, et al.

    Cureus 2026; (18(8)):e114369 doi:10.7759/cureus.114369.

    PMID: 42598653
  18. 18

    Living with a rare disorder: a systematic review of the qualitative literature.

    von der Lippe C, Diesen PS, Feragen KB

    Molecular genetics & genomic medicine 2017; (5(6)):758-773 doi:10.1002/mgg3.315.

    PMID: 29178638
  19. 19

    Exploring the Intersection of Rare Diseases and Mental Health Within the Diagnostic Odyssey: A Narrative Review and Thematic Synthesis.

    Wu E, Isobel S, Beckett P

    Nursing open 2026; (13(4)):e70488 doi:10.1002/nop2.70488.

    PMID: 41928379
  20. 20

    Rare Diseases of the Oral Cavity, Neck, and Pharynx.

    Reichel CA

    Laryngo- rhino- otologie 2021; (100(S 01)):S1-S24 doi:10.1055/a-1331-2851.

    PMID: 34352905

This page is for informational purposes only and does not constitute medical advice. Your hematology and cardiology team can interpret your test results and recommend monitoring for your specific situation.

Get notified when new evidence is published on Idiopathic hypereosinophilic syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.